the prognostic impact of flt3-itd and flt3-tkd in npm1-mutated aml
Published 1 year ago • 729 plays • Length 3:21Download video MP4
Download video MP3
Similar videos
-
1:49
the prognostic value of flt3-itd residual disease in aml
-
3:03
prognostic impact of flt3-itd in older patients with aml
-
0:35
management & outcome of patients with cbf aml and flt3-itd
-
3:18
the impact of secondary aml mutations on the prognosis of patients with npm1-mutated aml
-
0:51
unmet needs in front-line therapy for patients with flt3-mutated aml
-
1:12
the value of flt3 inhibitors in aml and focus for future trial designs
-
1:40
second-generation flt3 inhibitors in the treatment of flt3-itd aml
-
4:30
which gene mutations are categorized as low, intermediate and high risk aml? #aml
-
3:31
update on quantum-first: quizartinib soc chemotherapy & as continuation therapy in flt3-itd aml
-
9:45
discussing flt3-mutated aml: top ash data, triplets, and exciting future strategies
-
2:08
comparing midostaurin to next-generation flt3 inhibitors in the frontline treatment of flt3-itd aml
-
1:57
insights into the treatment of patients with flt3-mutated aml & the role of maintenance therapy
-
2:29
combining menin/flt3/bcl2 inhibition as a treatment approach in flt3/npm1 double mutated aml
-
2:45
prognostic signature for flt3-like wild type aml
-
1:32
novel treatment combinations for flt3-mutated aml
-
1:45
the impact of secondary-type mutations in npm1-mutated aml
-
0:49
admiral update: co-occurrence of dnmt3a, npm1 & flt3 mutations in patients treated with gilteritinib
-
4:43
treatment of npm1-mutated aml: intensive standard treatment
-
1:39
quantum-first: flt3-itd-specific mrd clearance is associated with improved os in newly diagnosed aml
-
3:36
the potential of palbociclib for the treatment of flt3-itd aml
-
1:59
optimizing the use of flt3 inhibitors in aml: sequencing, post-transplant maintenance & more
-
0:58
flt3 mutation clearance rate in patients with newly diagnosed aml